[The pre- and postoperative and follow-up use of the tumor markers MCA, CA-125 and CA-19-9].
The paper describes the authors' personal experience of the use of tumour markers, above all during postoperative follow-up as well as during the evaluation of the response to adjuvant and other forms of chemotherapy. The authors affirm that the use of these markers is fundamental for a correct evaluation and rapid treatment, above all in the identification and treatment of recidivation.
Zanon
C
C
Divisione di Chirurgia, Ospedale di Chivasso, Torino.
Alluminio
P
P
Margarita
V
V
Sottimano
C
C
Giuliani
F
F
Neri
G
G
Ballario
F
F
D000951:Antigens, Neoplasm / Q000097:blood*; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood*; D014408:Biomarkers, Tumor / Q000097:blood*; D001943:Breast Neoplasms / Q000175:diagnosis / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000601:surgery; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000601:surgery; D011182:Postoperative Care; D011300:Preoperative Care
D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; C057387:mucinous carcinoma-associated antigen
Utilizzazione pre- e postoperatoria e nel follow-up dei markers tumorali MCA, CA 125, CA 19,9.